MedPath

Tracsiban

Brand Name: Tracsiban

Generic Name: Atosiban (as acetate)

Active
Registration Number

DRP-14629

Dosage Form

Solution for Injection (IM/IV/SC)

Issuance Date

September 11, 2024

Expiry Date

September 11, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength7.5 mg (equivalent to 7.953 mg Atosiban Acetate)/mL
PackagingType I USP Clear Vial with Blue Aluminum Cap and Butyl Rubber Stopper x 5 mL (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Other Gynecologicals
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Atosiban (as acetate)Active
Monograph: atosiban (as acetate)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform